Clera home
·Dashboard

Jobs at Strand Therapeutics (Now Hiring) — 2 open

Strand Therapeutics logoStrand Therapeutics

Associate, Corporate Development

Boston, Massachusetts, United States · On-site

$100k–$150k/yr

Mid level$257M raised

Company Overview: Strand Therapeutics is a clinical-stage biotechnology company pioneering programmable mRNA therapeutics to unlock the full potential of genetic medicines. Strand is applying its proprietary Signal Stack…

Skills: Financial Modeling, Corporate Strategy, Due Diligence, Market Research, Competitive Intelligence

Strand Therapeutics logoStrand Therapeutics

Scientist / Senior Scientist, Process Sciences and Innovation

Boston, Massachusetts, United States · On-site

$120k–$142k/yr

Senior$257M raised

Company Overview: Strand Therapeutics is a clinical-stage biotechnology company pioneering programmable mRNA therapeutics to unlock the full potential of genetic medicines. Strand is applying its proprietary Signal Stack…

Skills: mRNA Synthesis, LNP Formulation, Process Development, Technology Scouting, Analytical Development

Strand Therapeutics logo

Associate, Corporate Development

Strand Therapeutics

Boston, Massachusetts, United States • On-site

Apply
Mid level

Tired of cold applications?

Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.

  • $100k–$150k/yr
  • Full-time
  • bachelor degree, postgraduate degree
  • Health Insurance, Dental Insurance, Life Insurance, Open PTO, Onsite Lunch Catering, Commuter Support
  • Posted 14d ago
  • ~40 hrs/week

Responsibilities

The role involves evaluating external assets and technologies to support business development, licensing, and corporate growth. It also requires building financial models and conducting market assessments to support strategic decision-making and investor relations.

Requirements

Candidates should have a Bachelor's or Advanced degree in Finance, Business, or a related field, with 2-4 years of experience in life sciences investment banking or consulting. Proficiency in financial analysis, due diligence, and executive-level communication is required.

Full job description

Company Overview:

Strand Therapeutics is a clinical-stage biotechnology company pioneering programmable mRNA therapeutics to unlock the full potential of genetic medicines. Strand is applying its proprietary Signal Stack platform, which integrates EverScript circular RNA, AmpliScript self-replicating RNA, SignalPath targeted delivery, and logic-driven SignalLock genetic circuits to enable precise control of therapeutic activity across tissues and cell types and overcome foundational limitations in targeting, durability, and safety.

Strand is advancing a pipeline with an initial focus on oncology and autoimmune disease. Its initial program, STX-001, an intratumorally delivered LNP-encapsulated self-replicating RNA expressing IL-12, has demonstrated preliminary evidence of systemic immune activation and anti-tumor activity in patients with advanced solid tumors who have progressed on prior therapies. Building on this early clinical validation, intravenously delivered STX-003 is designed for tumor-targeted expression and avoidance of off-target expression. STX-003, which is expected to enter the clinic in mid-2026, has the potential to be a major step forward for the fields of genetic medicine and oncology. Strand is also advancing STX-005, an in vivo CAR-T program designed to enable controlled, durable expression and repeat dosing. Founded by MIT synthetic biology pioneers, Strand has raised over $250 million and is headquartered in Boston, MA. 

Become the next standout single strand!

Job Summary:

Strand is looking for people who have the enthusiasm and motivation to be a highly contributing member of a small but extremely productive team.

We are looking for a highly motivated and innovative candidate for the role of Associate, Corporate Development. Reporting to Chief Financial Officer, the ideal candidate will combine strong financial, strategic, and scientific acumen to support corporate strategy, evaluate business opportunities, and drive value-creating initiatives across the organization. As the founding member of Strand's Corporate Development function, this individual will play a pivotal role in establishing and scaling best-in-class corporate development capabilities, processes, and strategic initiatives to support the company's long-term growth.

Primary Responsibilities:

  • Evaluate external assets, technologies, and platform opportunities to support business development, licensing, partnerships, and corporate growth initiatives.
  • Support the assessment and due diligence of licensing, collaboration, and other business opportunities through scientific, strategic, commercial, and financial analyses.
  • Support long-range financial plans, corporate valuation models, and scenario analyses to support strategic decision-making, capital allocation, and fundraising activities.
  • Build and maintain financial models, including valuation, transaction, and benchmarking analyses, to evaluate strategic opportunities and corporate performance.
  • Manage transaction execution activities, including coordinating diligence workstreams, organizing data rooms, tracking deliverables, and collaborating with internal and external stakeholders.
  • Conduct competitive intelligence and market assessments by monitoring industry trends, competitor pipelines, emerging technologies, financing activities, and M&A transactions.
  • Prepare presentations, analyses, and materials for executive leadership, the Board of Directors, investors, and other key stakeholders to support corporate strategy and investor relations activities.
  • Lead and support special projects, including strategic planning initiatives, expansion opportunities, acquisition target evaluations, and other ad hoc analyses to advance corporate objectives.

Qualifications:

  • Bachelor’s or Advanced Degree in Finance, Accounting, Business Administration or related field; MBA, CFA and/or other relevant credentials highly preferred.
  • 2-4 years of relevant experience in the life sciences industry, including investment banking, management consulting, corporate development, investor relations, or other strategic and financial roles.
  • Ability to conduct market research, competitive analysis, and industry assessments to identify strategic growth opportunities.
  • Proficiency in analyzing financial statements and evaluating business performance, risks, and growth drivers.
  • Prior experience with due diligence processes and transaction execution is highly desirab
  • Strong project management skills with the ability to manage multiple workstreams and coordinate cross-functional stakeholders.
  • Excellent written and verbal communication skills, including the ability to prepare executive-level presentations and recommendations.
  • Advanced proficiency in Microsoft Excel, PowerPoint, and financial data platforms.
  • Demonstrated ability to work independently in a fast-paced, dynamic environment while maintaining attention to detail.
  • Strong business judgment, strategic thinking, and problem-solving capabilities.

Strand offers a fast-paced, entrepreneurial, team-focused small company environment. We also offer a top-notch benefits package (health, dental, life, open PTO, onsite lunch catering, commuter support and more) and work/life flexibility and integration. Being part of the Strand team allows you to become part of a small team that supports professional development while working together to meet Strand’s goals. 

Strand Therapeutics is an equal opportunity employer. We do not discriminate on the basis of race, color, gender, gender identity, sexual orientation, age, religion, national or ethnic origin, disability, protected veteran status or any other basis protected by applicable law. Strand does not accept unsolicited resumes from any source other than directly from candidates.

Job Type: Full-time

Salary: $100,000 - $150,000 annually plus bonus and equity incentives

Pay Transparency Base Salary Range
$100,000—$150,000 USD

Related keywords

BiotechnologyCorporate DevelopmentmRNA TherapeuticsLife SciencesInvestment BankingManagement ConsultingCFAMBAM&ALicensingCapital AllocationInvestor RelationsOncologyAutoimmune DiseaseGenetic MedicineFinancial Data Platforms

About Strand Therapeutics

LinkedInVisit site

Where synthetic biology meets RNA therapeutics

Industry
Biotechnology Research
Company size
51-200 employees
Founded
2017
Headquarters
Boston, Massachusetts
LinkedIn followers
27,053
Total funding
$257M

Strand was founded by biological engineers working together at the Massachusetts Institute of Technology (MIT). Building on the idea of creating smart therapies capable of making sophisticated decisions, they sought to apply this concept to the emerging field of mRNA therapeutics. This area was previously untapped by traditional synthetic biology, leading us to build our very own mRNA programming language, creating the world’s first platform for mRNA smart therapies. Strand’s mRNA programming technology promises to make mRNA therapies safer and more effective by programming the location, timing, and intensity of therapeutic protein expression inside a patient’s body via mRNA-encoded logic circuits. These circuits have the ability to implement cell-type specific expressions by sensing and classifying the unique mRNA expression signatures of cells and control the dosage of protein expression through responses to exogenously administered small molecules.

Offices: 21-27 Burlington Ave, Boston, Massachusetts 02215, US

biotechnologysynthetic biologyRNA therapeuticsand ImmunotherapyBiotechnologyLife SciencePharmaceuticalTherapeutics
View all jobs at Strand Therapeutics

About Strand Therapeutics

LinkedInVisit site

Where synthetic biology meets RNA therapeutics

Industry
Biotechnology Research
Company size
51-200 employees
Founded
2017
Headquarters
Boston, Massachusetts
LinkedIn followers
27,053
Total funding
$257M

Strand was founded by biological engineers working together at the Massachusetts Institute of Technology (MIT). Building on the idea of creating smart therapies capable of making sophisticated decisions, they sought to apply this concept to the emerging field of mRNA therapeutics. This area was previously untapped by traditional synthetic biology, leading us to build our very own mRNA programming language, creating the world’s first platform for mRNA smart therapies. Strand’s mRNA programming technology promises to make mRNA therapies safer and more effective by programming the location, timing, and intensity of therapeutic protein expression inside a patient’s body via mRNA-encoded logic circuits. These circuits have the ability to implement cell-type specific expressions by sensing and classifying the unique mRNA expression signatures of cells and control the dosage of protein expression through responses to exogenously administered small molecules.

Offices: 21-27 Burlington Ave, Boston, Massachusetts 02215, US

biotechnologysynthetic biologyRNA therapeuticsand ImmunotherapyBiotechnologyLife SciencePharmaceuticalTherapeutics
View all jobs at Strand Therapeutics

Similar companies hiring

Thermo Fisher Scientific (2347)Roche (1165)CSL (987)Amgen (870)ICON plc (736)Syneos Health (400)Mineralys Therapeutics, Inc. (314)Fortrea (252)Agilent Technologies (247)Gilead Sciences (204)BeiGene (174)Genentech (172)
Clera home

Your AI-talent agent. Connecting talents with dream jobs.

Earn $5,000

Tools

  • Salary Calculator
  • Resume Review
  • Startup Map

Explore

  • Jobs
  • Discover Jobs
  • Companies
  • Case Studies
  • Referral

Platform

  • Pricing
  • Integrations
  • Partners
  • Acquihire

Clera

  • Manifesto
  • Engineering
  • We are hiring!
  • FAQs
  • Blog
  • Press

Tools

  • Salary Calculator
  • Resume Review
  • Startup Map

Explore

  • Jobs
  • Discover Jobs
  • Companies
  • Case Studies
  • Referral

Platform

  • Pricing
  • Integrations
  • Partners
  • Acquihire

Clera

  • Manifesto
  • Engineering
  • We are hiring!
  • FAQs
  • Blog
  • Press

© 2026 Clera Labs, Inc.

PrivacyTermsBug Bounty